PARP inhibitors (class)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PARP inhibitors (class), covering 2026-02-23 to 2026-02-23. Get the full timeline:
Most recent: Clinical Trial Update: Study on the Relative Dose Intensity of PARP Inhibitors in Real-life on a Population of Patients Over 70 Years With Advanced Ovarian Cancer